Nitisinone
ATC A16AX04 · 7 markets · 78 records
US 23 records · 8 strengths
AU 13 records · 7 strengths
- 10 mgcapsuleORFADINORFADIN nitisinone 2 mg capsule bottle
- 5 mgcapsuleORFADINORFADIN nitisinone 2 mg capsule bottle
- 2 mgcapsuleORFADINORFADIN nitisinone 2 mg capsule bottle
- 20 mgcapsuleORFADINORFADIN nitisinone 2 mg capsule bottle
- 4 mgliquidORFADIN nitisinone 4 mg/mL oral suspension bottle
- 4 mg/1 mLliquidORFADIN
Records without a stated strength · 1 NITYR、ORFADIN
GB 12 records · 5 strengths
ES 12 records · 5 strengths
- 10 mgcapsuleNITISINONA DIPHARMANITISINONE MDK、ORFADIN
- 5 mgcapsuleNITISINONA DIPHARMANITISINONE MDK、ORFADIN
- 2 mgcapsuleNITISINONA DIPHARMANITISINONE MDK、ORFADIN
- 20 mgcapsuleNITISINONA DIPHARMAORFADIN
- 4 mg/1 mLliquidORFADIN
CA 8 records · 5 strengths
- 10 mgcapsuleMDK-NITISINONEORFADIN
- 5 mgcapsuleMDK-NITISINONEORFADIN
- 2 mgcapsuleMDK-NITISINONEORFADIN
- 20 mgcapsuleORFADIN
- 4 mgliquidORFADIN
CN 3 records · 3 strengths
- 10 mgcapsuleManufacturer: MENDELIKABS INC ×3
- 5 mgcapsuleManufacturer: MENDELIKABS INC ×3
- 2 mgcapsuleManufacturer: MENDELIKABS INC ×3
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ORFADIN
| Strength / form / release | US | GB | CA | AU | CN | ES | EU |
|---|---|---|---|---|---|---|---|
| 10 mg capsule | No trade name ORFADIN | No trade name ORFADIN | MDK-NITISINONE ORFADIN | ORFADIN ORFADIN nitisinone 2 mg capsule bottle | Manufacturer: MENDELIKABS INC ×3 | NITISINONA DIPHARMA NITISINONE MDK ORFADIN | |
| 5 mg capsule | No trade name ORFADIN | No trade name ORFADIN | MDK-NITISINONE ORFADIN | ORFADIN ORFADIN nitisinone 2 mg capsule bottle | Manufacturer: MENDELIKABS INC ×3 | NITISINONA DIPHARMA NITISINONE MDK ORFADIN | |
| 2 mg capsule | No trade name ORFADIN | No trade name ORFADIN | MDK-NITISINONE ORFADIN | ORFADIN ORFADIN nitisinone 2 mg capsule bottle | Manufacturer: MENDELIKABS INC ×3 | NITISINONA DIPHARMA NITISINONE MDK ORFADIN | |
| 20 mg capsule | No trade name ORFADIN | No trade name ORFADIN | ORFADIN | ORFADIN ORFADIN nitisinone 2 mg capsule bottle | NITISINONA DIPHARMA ORFADIN | ||
| 4 mg liquid | ORFADIN | ORFADIN | ORFADIN | ORFADIN nitisinone 4 mg/mL oral suspension bottle | |||
| 2 mg tablet | HARLIKU NITYR | ||||||
| 4 mg/1 mL liquid | ORFADIN | ORFADIN | |||||
| 10 mg tablet | NITYR | ||||||
| 5 mg tablet | NITYR | ||||||
unknown | NITYR ORFADIN | ORFADIN |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.